These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography. Dilsizian V, Perrone-Filardi P, Arrighi JA, Bacharach SL, Quyyumi AA, Freedman NM, Bonow RO. Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921 [Abstract] [Full Text] [Related]
3. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883 [Abstract] [Full Text] [Related]
4. Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction. Perrone-Filardi P, Bacharach SL, Dilsizian V, Maurea S, Frank JA, Bonow RO. Circulation; 1992 Oct; 86(4):1125-37. PubMed ID: 1394920 [Abstract] [Full Text] [Related]
5. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose. Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL, Marin-Neto JA, Katsiyiannis PT, Bonow RO. Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546 [Abstract] [Full Text] [Related]
6. Regional thallium uptake in irreversible defects. Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. Dilsizian V, Freedman NM, Bacharach SL, Perrone-Filardi P, Bonow RO. Circulation; 1992 Feb; 85(2):627-34. PubMed ID: 1735157 [Abstract] [Full Text] [Related]
8. [Thallium scintigraphy for determining myocardial vitality. Evaluation of the "stunned and hibernating myocardium"]. Nienaber CA, Carnarius H. Herz; 1994 Feb; 19(1):7-18. PubMed ID: 8150416 [Abstract] [Full Text] [Related]
9. 13N-ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization. Kitsiou AN, Bacharach SL, Bartlett ML, Srinivasan G, Summers RM, Quyyumi AA, Dilsizian V. J Am Coll Cardiol; 1999 Mar; 33(3):678-86. PubMed ID: 10080468 [Abstract] [Full Text] [Related]
10. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. N Engl J Med; 1990 Jul 19; 323(3):141-6. PubMed ID: 2362606 [Abstract] [Full Text] [Related]
11. Differential uptake and apparent 201Tl washout after thallium reinjection. Options regarding early redistribution imaging before reinjection or late redistribution imaging after reinjection. Dilsizian V, Bonow RO. Circulation; 1992 Mar 19; 85(3):1032-8. PubMed ID: 1537101 [Abstract] [Full Text] [Related]
12. Thallium-201 redistribution after early reinjection in patients with severe stress perfusion defects and ventricular dysfunction. Galli M, Marcassa C. Am Heart J; 1994 Jul 19; 128(1):41-52. PubMed ID: 8017283 [Abstract] [Full Text] [Related]
13. Thallium 201 for assessment of myocardial viability. Bonow RO, Dilsizian V. Semin Nucl Med; 1991 Jul 19; 21(3):230-41. PubMed ID: 1948113 [Abstract] [Full Text] [Related]
14. Comparison of rest-redistribution thallium-201 imaging and reinjection after stress-redistribution for the assessment of myocardial viability in patients with left ventricular dysfunction secondary to coronary artery disease. Galassi AR, Centamore G, Fiscella A, Coppola A, Liberti F, Franco M, Palazzo G, Musumeci S, Galassi A. Am J Cardiol; 1995 Mar 01; 75(7):436-42. PubMed ID: 7863985 [Abstract] [Full Text] [Related]
15. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. Vanoverschelde JL, D'Hondt AM, Marwick T, Gerber BL, De Kock M, Dion R, Wijns W, Melin JA. J Am Coll Cardiol; 1996 Aug 01; 28(2):432-42. PubMed ID: 8800122 [Abstract] [Full Text] [Related]
16. Theoretical model for myocardial functional characterization: application to a group of patients evaluated before and after surgical revascularization. Bontemps L, Nazzi M, Gabain M, Jegaden O, Felecan R, Itti R. J Nucl Cardiol; 1998 Aug 01; 5(2):134-43. PubMed ID: 9588665 [Abstract] [Full Text] [Related]
17. Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Gunning MG, Anagnostopoulos C, Knight CJ, Pepper J, Burman ED, Davies G, Fox KM, Pennell DJ, Ell PJ, Underwood SR. Circulation; 1998 Nov 03; 98(18):1869-74. PubMed ID: 9799206 [Abstract] [Full Text] [Related]
18. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, Shea NL, Oates E, Konstam MA. Circulation; 1994 Jun 03; 89(6):2552-61. PubMed ID: 8205664 [Abstract] [Full Text] [Related]